David Greenberg, MD, FACP, section chief of Hematology/Oncology at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, who was not involved in this study, commented that he was not surprised by this studys results, as weve known for decades that lifestyle, obesity, and My cardiology colleagues have promoted GLP-1 drugs for several years to potentially improve a patients overall health, Greenberg told Medical News Today
PMID: 10 ScottiLFranchiMMarchesoniACorraoG
The VESPER-6 Phase 3 study investigating monthly maintenance dosing for berobenatide in adults with obesity or overweight is open for enrollment, as well as the SOLIS-1 Phase 2b study investigating weekly and monthly maintenance dosing of an ultra-long-acting amylin analog (PF3945) as a monotherapy and in combination with berobenatide
But some people have little success losing weight with the drugs and experience significant side effects
Fibroblast and collagen regulation : It promotes tendon, ligament, and muscle remodeling by supporting structural repair
Growing evidence from observational studies indicates that treatment of obesity with bariatric surgery improves cardiovascular outcomes, but these findings have not been confirmed in randomized trials, largely because of randomization challenges with bariatric surgery